Tarsus Pharmaceuticals (TARS) PT Raised to $101 at Mizuho
Mizuho analyst Graig Suvannavejh raised the price target on Tarsus Pharmaceuticals (NASDAQ: TARS) to $101.00 (from $100.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
